Data Triumph at C Cancer Cell

Slides:

Advertisements

Similar presentations

Irreplaceability of Neuronal Ensembles after Memory Allocation Naoki Matsuo Cell Reports Volume 11, Issue 3, Pages (April 2015) DOI: /j.celrep

Advertisements

Cancer Metabolism Cell Volume 148, Issue 3, (February 2012) DOI: /j.cell Copyright © 2012 Terms and Conditions Terms and Conditions.

National Guidelines for Nursing Delegation

Nanostructures: Current uses and future applications in food science

Untangling P-Bodies: Dissecting the Complex Web of Interactions that Enable Tiered Control of Gene Expression Christopher J. Kershaw, Mark P. Ashe Molecular.

Kristin G. Anderson, Ingunn M. Stromnes, Philip D. Greenberg

J. Egea, A.G. García, J. Verges, E. Montell, M.G. López

Reactive oxygen species in the normal and acutely injured liver

Obesity, inflammation, and liver cancer

Nomeda Girnius, Roger J. Davis Cancer Cell

New Animal Models for Parkinson's Disease

Dylan Burger, Adeera Levin Kidney International

Christian Grommes, Anas Younes Cancer Cell

NAD+ Supplementation as a Novel Approach to cURIng HCC?

Driving Glioblastoma to Drink

Radiotherapy Complements Immune Checkpoint Blockade

Fatty Acid-Induced T Cell Loss Greases Liver Carcinogenesis

Michael W.M. Kühn, Scott A. Armstrong Cancer Cell

No Need for Constant Help: Human IgG2 Antibodies Have an Autonomous Agonistic Activity for Immunotherapy of Cancer Anja Lux, Falk Nimmerjahn Cancer.

Mutant p53 in Cancer: New Functions and Therapeutic Opportunities

Cliques and Schisms of Cancer Genes

Michael W.M. Kühn, Scott A. Armstrong Cancer Cell

A Radical Role for p38 MAPK in Tumor Initiation

Zhihua Liu, Michael J. Lenardo Developmental Cell

When LMO1 Meets MYCN, Neuroblastoma Is Metastatic

Apoptosis, Up the Ante Cancer Cell

Volume 26, Issue 6, Pages (December 2014)

Choose and Use Your Chemical Probe Wisely to Explore Cancer Biology

Volume 137, Issue 1, Pages (July 2009)

Eukaryotic Transcription Activation: Right on Target

Volume 152, Issue 1, (January 2013)

YAP/TAZ at the Roots of Cancer

Untangling P-Bodies: Dissecting the Complex Web of Interactions that Enable Tiered Control of Gene Expression Christopher J. Kershaw, Mark P. Ashe Molecular.

Killing Lymphoma with Smac-Mimetics: As Easy as ABC?

Volume 130, Issue 6, (September 2007)

Kabir A. Khan, Robert S. Kerbel Cancer Cell

A New FOXO Pathway Required for Leukemogenesis

Negative Feedback Mechanisms and Their Roles during Pattern Formation

Matthias H. Tschöp, Michael Stumvoll, Michael Ristow Cell Metabolism

Volume 143, Issue 6, (December 2010)

A Translational View of the Molecular Pathogenesis of Lung Cancer

Therapeutic strategies in inflammasome mediated diseases of the liver

Bacterial Adhesins in Host-Microbe Interactions

Apoptosis Cell Volume 108, Issue 2, Pages (January 2002)

T Cell Dysfunction in Cancer

Inflammation, ROS, and Mutagenesis

Organization news Archives of Physical Medicine and Rehabilitation

The Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Lung Cancer: Still Following the Right TRAIL? Emmet E. McGrath, MB, PhD Journal of Thoracic.

Intratumoral hypoxia, radiation resistance, and HIF-1

Molecular mechanisms of renal hypertrophy: Role of p27Kip1

A Missing Link in Genotype-Directed Cancer Therapy

RIPK3 Slams the Brake on Leukemogenesis

The new kid on the block(ade) of the IGF-1 receptor

Splicing and Dicing MYC-Mediated Synthetic Lethality

Khalid S. Mohammad, Theresa A. Guise Cancer Cell

TFIID and MYB Share a Therapeutic Handshake in AML

P.E. Vlisides, M.S. Avidan, G.A. Mashour

Volume 10, Issue 3, Pages (September 2006)

Nathalie Ganne-Carrié, Pierre Nahon Journal of Hepatology

Volume 163, Issue 4, (November 2015)

All Roads Lead to the Ribosome

Volume 163, Issue 2, (October 2015)

ROS: Really involved in Oxygen Sensing

c-Raf in KRas Mutant Cancers: A Moving Target

The Tribble with APL: A New Road to Therapy

Volume 134, Issue 6, (September 2008)

Long Noncoding RNAs in Cancer Pathways

In This Issue Cell Volume 145, Issue 3, (April 2011)

On the Road to Bacterial Cell Death

Mutant p53 in Cancer: New Functions and Therapeutic Opportunities

Presentation transcript:

Data Triumph at C Cancer Cell Mark Levine, Pierre-Christian Violet Cancer Cell Volume 31, Issue 4, Pages 467-469 (April 2017) DOI: 10.1016/j.ccell.2017.03.008 Copyright © 2017 Terms and Conditions

Figure 1 Pharmacologic Ascorbate Mediation of Cancer Cell Death Pharmacologic ascorbate is a pro-drug for formation of extracellular H2O2. H2O2 diffuses intracellularly and interacts with iron or other metal centers to form reactive oxygen species (ROS). ROS modulate multiple downstream pathways and targets that induce cancer cell death. Cancer Cell 2017 31, 467-469DOI: (10.1016/j.ccell.2017.03.008) Copyright © 2017 Terms and Conditions